6676 logo

Sunny Pharmtech Inc. Stock Price

TPEX:6676 Community·NT$1.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6676 Share Price Performance

NT$0
-22.35 (-100.00%)
NT$0
-22.35 (-100.00%)
Price NT$0

6676 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with imperfect balance sheet.

3 Risks
0 Rewards

Sunny Pharmtech Inc. Key Details

NT$290.2m

Revenue

NT$134.7m

Cost of Revenue

NT$155.5m

Gross Profit

NT$425.0m

Other Expenses

-NT$269.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-1.81
53.58%
-92.88%
43.7%
View Full Analysis

About 6676

Founded
2014
Employees
158
CEO
Yon-Lian Wu
WebsiteView website
www.sunnypharmtech.com

Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug in Taiwan, the United States, and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for blood diseases, as well as for hyper-proteolytic enzymes; and carboprost tromethamine injection for therapeutic abortion and postpartum hemorrhage, as well as Cyclophosphamide injection for malignant diseases. The company was founded in 2014 and is based in Taoyuan, Taiwan.

Recent 6676 News & Updates

Recent updates

No updates